跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,641 条关于
“gastroenteropancreatic NETs”
全部
1,641
临床试验
702
药物
52
机构
11
资讯
876
去年
NETTER-2 Trial: 177Lu-Dotatate Shows Promise but Raises Questions in High-Grade NETs
2年前
Sanofi, RadioMedix, and Orano Med Partner to Develop Radioligand Therapy for Rare Cancers
去年
Lutetium-177 Dotatate Shows Promise in Neuroendocrine Tumors, Combination Strategies Explored
去年
Clarity Pharmaceuticals' 64Cu-SARTATE Shows Superior Lesion Detection in Phase II DISCO Trial for Neuroendocrine Tumors
去年
Neuroendocrine Tumor Pipeline Shows Strong Growth with 75+ Therapies in Development
去年
ITM-11 Demonstrates Superior Progression-Free Survival Compared to Everolimus in GEP-NETs
去年
Afinitor Plus Somatuline Significantly Prolongs Survival in GEP-NETs
去年
Everolimus Plus Lanreotide Significantly Extends PFS in GEP-NETs
6个月前
ITM to Present Pancreatic Neuroendocrine Tumor Subgroup Analysis from Phase 3 COMPETE Trial at ENETS 2026
去年
Grand Pharmaceutical's ITM-11 Phase III Trial Accepted for GEP-NETs in China
第 1 页，共 88 页
上一页
下一页
